Monday, 6 April 2020

Healthcare Fraud Detection Software Market Strategic Assessment, Research, Region, Share And Global Expansion By 2024

Global Healthcare Fraud Detection Market: Information by Type (Descriptive Analytics, Predictive Analytics and Prescriptive Analytics), by Component (Services and Software), by Delivery Model (On-Premise and Cloud-Based), by Application (Insurance Claims Review and Payment Integrity), by End User (Private Insurance Payers, Public/Government Agencies and Third Party Service Providers) and by Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2024

Healthcare Fraud Detection Software Market Overview
The problem of fraudulent claims is intensifying in the healthcare sector and is a burden to society. Healthcare fraud detection generally involves account auditing and detective investigation for fraudulent activities. Some of the common healthcare fraud cases include billing for services that are not provided, separate billing for laboratory tests performed together to claim higher reimbursements, usage of healthcare cards by others, and many more. Such fraudulent activities are detected by using statistical, analytical, deep learning, and predictive modeling methods. The healthcare sector is witnessing more payment breaches than ever before due to which the adoption of healthcare fraud detection solutions has gained enormous importance. Market Research Future (MRFR) has launched a new report on the global Healthcare Fraud Detection Software Market and has indicated that the market is primed to capture a CAGR of 26.7% over the forecast period of 2018-2023. The healthcare fraud detection market was valued at USD 639.07 Mn in 2017.

Misinterpretation, as well as intentional deceit in facts related to payments, have given rise to the need for robust fraud detection systems. Various healthcare organizations across the globe are augmenting their anti-fraud initiatives with proprietary detection technologies. Deployment of such solutions helps to reduce common falsification activities such as multiple claims filed by different providers for same patient, intentional misrepresentation of dates, duration, frequency, or description of services provided. As greater number of patients are seeking healthcare insurance, the chance of healthcare fraudulent activities are also increasing manifold.

On the other hand, despite various benefits aligned with fraud detection solutions, their implementation is restricted by time-consuming deployment process and the need for frequent software upgrades.

Healthcare Fraud Detection Software Market Segmentation
The healthcare fraud detection market has been segmented based on component, delivery model, type, application, end-user.

By component, the healthcare fraud detection market has been segmented into services and software.
By delivery model, the healthcare fraud detection market has been segmented into on-premise delivery models and on-demand delivery models.

By type, the healthcare fraud detection market has been segmented into descriptive analytics, predictive analytics, and prescriptive analytics. Descriptive analytics is the base for effective application of predictive or prescriptive analytics and the descriptive analytics segment is thus anticipated to lead the market.  
By application, the healthcare fraud detection market has been segmented into insurance claims review and payment integrity. The insurance claims review segment has been further segmented into post-payment review and prepayment review.

By end-user, the healthcare fraud detection market has been segmented into private insurance payers, government agencies, employers, and others. 

Healthcare Fraud Detection Software Market Regional Analysis
Region-wise, the healthcare fraud detection market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The Americas is governing the global fraud detection market. The rising number of fraudulent activities in the region, along with government initiatives to curb frauds in the healthcare sector is boosting the growth of the market. Increased spending on healthcare IT, the presence of major players in the region, and technological advancements in the region are other driving factors.

The spiraling rise in the number of healthcare forgery and corruption incidents in Europe has significantly driven the healthcare fraud detection market in the region. The governments in the region are endeavoring to integrate IT into the healthcare infrastructure and are outlaying significant amounts on the same.

APAC healthcare fraud detection market is slated to expand at a torrid pace over the forecast period. Swiftly developing healthcare sector, surging incidence rate of cybercrimes in the region, and increased investment in healthcare IT are propelling the growth of the market in APAC.

The MEA market is likely to capture the least share of the market over the forecast period. The majority of the market growth is anticipated to be cornered towards the Middle East, where investments are being poured in for the development of the healthcare sector due to rising incidences of health insurance frauds.


Healthcare Fraud Detection Market Competitive Landscape
International Business Machines Corporation (IBM), Wipro, HCL Technologies, SAS Institute, Northrop Grumman, McKesson, Fair Isaac, Scio Health Analytics, Pondera Solutions, Conduent, Optum, Verscend Technologies, LexisNexis, DXC Technology, and CGI Group are the eminent players in the healthcare fraud detection market.

Healthcare Fraud Detection Industry Updates
August 2019 - Deep Labs, am AI-driven technology company partnered with Visual Connections, provider of a spectrum of cutting-edge IT services and solutions, to develop AI-driven healthcare fraud detection system.
Posted by at No comments:
Labels:

Friday, 3 April 2020

Healthcare CRM Market 2020: Historical Analysis, Opportunities, Latest Innovations And Top Players

Global Healthcare CRM Market Overview
A healthcare customer relationship management (CRM) tool aids in an efficient approach for interaction management with patients. It also enables the management, coordination, and automation of various business processes. A healthcare customer relationship management analyzes and segments patient populations helping in the measurement of the success of engagement tactics.

The global healthcare CRM market is estimated to witness a 13.8% CAGR throughout the forecast period of 2018-2023. A rapid ascension in the adoption of customer relationship management software in the healthcare sector can be consequential to numerous benefits provided by a CRM system. Comfortable customer data arrangement and simple interactions are some of the benefits of a CRM solution driving a healthcare CRM solution market. Further, the simplification of many business processes, including customer service and support, marketing, sales, and digital marketing is promoting the adoption of CRM systems in the healthcare sector.

Moreover, a growing emphasis on patient engagement and rising demand for structured data are fueling the healthcare CRM market to a great extent. Increasing penetration of automation of various processes with the use of software and solutions is pushing the healthcare sector to keep up with the trend by adopting advanced CRM systems during the conjectured time period.

Even though numerous factors are working in favor of the healthcare CRM market, high cost and complexity relating to CRM are posing as hindrances in the growth rate of the market. Additionally, raising concerns regarding data security is creating hesitation in the adoption of CRM systems in the healthcare sector through the assessment period.
Healthcare CRM Market Segmentation
MRFR segments the global healthcare CRM market on the basis of components, deployment model, functionality, end-users, and region. Based on component, the healthcare CRM market is segmented into services and software. Among these segments, the services segment is projected to expand at the highest CAGR owing to the vital role of service providers in the use of CRM solutions for healthcare.

Based on deployment model, the global healthcare CRM market is segmented into on-premise model and web/cloud-based model. The web/cloud-based model is further sub-segmented into public cloud, hybrid cloud, and private cloud. The web/cloud-based model is expected to showcase significant growth during the forecast period.
Based on functionality, the global healthcare CRM market is segmented into customer service and support, marketing, sales, and digital marketing. The segmentation based on end-users includes healthcare providers, healthcare payers, and life science industry.

Healthcare CRM Market Regional Analysis
Based on geography, the global healthcare CRM market is segmented into the Americas, Asia Pacific, Europe, and the Middle East & Africa. The Americas are further segmented into North America and South America. Americas are estimated to spearhead the healthcare CRM market during the prediction period. Such market command can be accredited to the mounting clinical and R&D budgets by governments in both the sub-segments to encourage the adoption of healthcare IT and electronic health record (EHR). Conferring to the U.S. Department of Health and Human Services, in 2015, around 84% of hospitals were observed adopting a basic HER system in the U.S.  

Europe is projected to grasp the second largest share in the global healthcare CRM market. This rate of growth can be attributed to the excellent network and IT development witnessed by the region in recent years. Also, a growing effort of CRM providers to develop and commercial artificial intelligence and analytics-powered innovative CRM solutions is fueling growth in the regional market.

Asia Pacific is estimated to surge at the fastest rate during the forecast period. Such growth can be owed to the improving quality of healthcare systems, increasing introduction of supportive government initiatives, and rising medical tourism market in the region.


Healthcare CRM Market Key Players
Some of the notable players in the healthcare CRM market include Saleforce.Com, Inc., Oracle, Microsoft, IBM, SAP SE, Influence Health, Inc., Accenture, Healthgrades, Infor, Inc., Amdocs Ltd., Anthelio Healthcare Solutions, AllScripts Healthcare Solutions Inc., and NetSuite.

Healthcare CRM Industry Update
May 2019: VERB technology announced its collaboration with PrimeMyBody for a sales app and digital platform. This app will be launched by PrimeMyBody, which will include product sampling and VERB’s interactive tag video features and its functionality. This app is likely to aid PrimeMyBody distributors to enhance many processes, including custom drip email campaigns, track and measure the engagement, and get detailed analytics.
Posted by at No comments:
Labels:

AI in Healthcare Market Leading Players, Current Trends, Challenges, Business Strategies, Emerging Technologies

Healthcare Artificial Intelligence (AI) Market Synopsis
Market Research Future (MRFR) asserts that the global Artificial Intelligence in Healthcare market is estimated to demonstrate 51.9% CAGR during the forecast period (2018-2023). Rising application of AI in the field of drug discovery is favoring the AI in Healthcare Market growth to a large extent. Artificial intelligence (AI) is referred to as the engineering and science which is adopted to design intelligent machines like intelligent computer programs. It is a system which applies several human intelligence-based functions like learning, reasoning, and problem-solving skills on disciplines like computer science, biology, linguistics, mathematics, and engineering. Artificial intelligence is considered the next frontier for healthcare innovation. AI in healthcare is implemented for sorting both structured and unstructured data. Fields of healthcare like oncology, neurology, and cardiology are experiencing a growing application of AI.

Healthcare Artificial Intelligence (AI) Market Potential and Pitfalls
Artificial Intelligence has developed several applications in the healthcare sector, such as delivery of health services, detection of diseases, drug discovery, and management of chronic diseases. It ensures effectiveness and efficiency which is likely to trigger its adoption rate in the coming years. AI has also strengthened its foothold in the healthcare research sector for delivering accurate results. This has further contributed to the growth of the market throughout the estimated period. The technology also helps to overcome the human resource crisis by providing increased productivity by automation of complicated tasks. With the increased application of AI in the field of the medical imaging industry, drug discovery, genomics, and precision medicine combined with the rising personalized treatments customized according to the requirements of an individual patient, the global Artificial Intelligence in Healthcare market is estimated to flourish.

The demand for artificial intelligence in order to perform data mining and trigger the speed of healthcare delivery services has increased. Moreover, the advent of novel and promising applications for diagnosing and monitoring the disease is predicted to contribute to the market growth throughout the assessment period. Advancements made in the data analytics will further propel the Artificial Intelligence in Healthcare market in the coming years. With a massive amount of data being generated every year in the healthcare sector coupled with the ever-increasing volume of big data has created the need to adapt AI so that data can be managed effectively. The AI research team of Google has recently launched its Google Deepmind Health project for data mining of medical records in order to offer better and faster services.

On the contrary, strict mandates regulating AI and high cost associated with its implementation are anticipated to slowdown the market growth throughout the assessment period. Moreover, the reluctance among the healthcare professionals and an imprecise regulatory scenario in order to adopt such technologies are presumed to hinder the market growth in the coming years.

Global Artificial Intelligence in Healthcare Market: Segmental Analysis
The global Artificial Intelligence in Healthcare market has been segmented on the basis of component, application, technology, and end-users.

By mode of component, the healthcare AI market has been segmented into software, hardware, and services.
By mode of application, the healthcare AI market has been segmented into virtual nursing assistant, robot-assisted surgery, clinical trial, dosage error reduction, automated image diagnosis, and preliminary diagnosis. Among these, the robot-assisted surgery is predicted to occupy a significant share owing to the high flexibility and precision ensured by robot-assisted surgeries during performing complicated procedures.

By mode of technology, the healthcare AI market has been segmented into querying method, machine learning, and natural language processing. Among these, the machine-learning segment is predicted to experience the highest CAGR owing to the ability to handle multiple dimensional data while enabling a reduction in the process time cycle.
By mode of end-users, the global Artificial Intelligence in Healthcare market has been segmented into pharmaceutical & biotechnology companies, hospital & diagnostic centers, and academic & research laboratories. Among these, the hospitals & diagnostic centers occupy the largest market share owing to the extensive application of AI in diagnostic imaging and robotic surgeries.

Healthcare Artificial Intelligence (AI) Market Regional Insights
Geographically, the Artificial Intelligence in Healthcare market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Among all the regions, the American region is estimated to dominate the AI in the healthcare market and is likely to retain its dominance in the coming years. The growth in this region is credited to the growth witnessed in the biotechnology sector. Moreover, the augmenting cases of robotics surgeries coupled with the presence of a well-developed healthcare sector are contributing to the growth of the market in this region.

The European region has secured the second position and is estimated to garner USD 3453.4 million during the appraisal period. The factors catalyzing the proliferation of the market are the extensive R&D made for healthcare AI combined with the rising funding.

Meanwhile, the Asia Pacific region is likely to register 52.4% CAGR in the coming years owing to the increased therapeutic demand for chronic diseases. Also, the fast-developing healthcare sector is influencing the market growth to a large extent.


Healthcare Artificial Intelligence (AI) Industry Updates
February 21, 2019: A team of scientists from the University of California and the University of Surrey has together used AI network in order to identify and scrutinize the symptoms in patients suffering from cancer. The new study elaborates how researchers have used network analysis in order to examine the relationship and structure between 38 common symptoms reported by the cancer patients receiving chemotherapy.

Healthcare Artificial Intelligence (AI) Market Competitive Dashboard
The prominent players operating the Artificial Intelligence in Healthcare market are Koninklijke Philips N.V., IBM Watson Health, NVIDIA Corporation, CloudMedx Inc., Microsoft Corporation, Google, General Electric, Next IT Corp., Intel Corporation, DEEP GENOMICS, General Vision, and Stryker.

Posted by at No comments:
Labels:

Veterinary CBD Market Size, Industry Analysis, Key Findings, Share, Research, Development Status

Veterinary CBD Market Overview
Global veterinary CBD market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 36.3%, surpassing a valuation of USD 17.345 billion during the forecast period till 2025.

CBD pet products possess anti-inflammation and anti-anxiety properties, which are the primary growth stimulants of the veterinary CBD market. The market is estimated to garner an impressive CAGR, mainly due to the surging number of household pets and mounting demand for humane practices in livestock management. The easing restrictions governing the utilization of CBD products in order to treat several ailments are estimated to propel the market growth in the coming years. As the pet care market globally seems to witness a never-ending rise, CBD infused products will garner revenues. The surging adoption of pets and soaring demand for premium care products are likely to encourage the market growth across the globe.

On the contrary, the unclear regulatory environment for the utilization of CBD products, coupled with the manufacturing of source product are estimated to deter the market growth in the foreseeable future.

Global Veterinary CBD Market: Segmental Analysis
The veterinary CBD market has been segmented on the basis of source, product, and distribution channel.
By source, the Pet CBD market is segmented into marijuana-derived and hemp-derived. Of these, marijuana-derived veterinary CBD is considered completely legal in South Africa, Canada, and a few US states. It is one of the top raw materials for CBD products owing to the potency of the THC. Several countries are likely to legalize marijuana in the coming years due to its medicinal values.

The product segment includes therapeutic-grade, food-grade, and personal care. Of these, the therapeutic-grade is estimated to be the fastest-growing segment owing to the rising support for these products, especially by the veterinarians. Also, the rising consumer concern for the mental wellbeing of pets has influenced the market growth in the segment.

The distribution channel is segmented into retail pharmacies, e-commerce websites, veterinary clinics, and others. Of these, the e-commerce websites channels are considered one of the best distribution channels for these products due to the current boom in e-commerce and easy availability of these products online.

Veterinary CBD Market Regional Frontiers
Geographically, the veterinary CBD market spans across the Asia Pacific, America, Europe, and the Middle East & Africa.

Considering the global scenario, America is estimated to lead the veterinary CBD market owing to the legislative allowances for marijuana, coupled with the large-scale infrastructure support for new industries. The veterinary market is concentrated in this region, but there is significant untapped potential in other regions as well, mainly due to the surging number of pets and increased spending on pets.

Europe is an emerging market for veterinary CBD. Increased focus on pet health and a well-established tradition for implementation and research has made the region a strong contender to the market in North America.

The Asia Pacific boasts the highest number of livestock and pets, and the regional market is presently limited by regulatory norms and high preference for traditional medical practices. The region promises aggressive market growth as it is the largest producer of hemp and has a recorded history of medicinal marijuana use.


Veterinary CBD Industry Updates
August 2019: A global leading hemp and cannabis wellness brand for pets, True Leaf Brands Inc. has recently declared that the company has launched its veterinarian-formulated, cannabidiol (CBD) supplements, especially for dogs at SuperZoo 2019.

Veterinary CBD Market Competitive Dashboard
The top players operating in the veterinary CBD market include HolistaPet (US), Honest Paws (US), Canna-Pet (US), HempMy Pet (US), Fomo Bones (US), Joy Organics (US), Green Roads of Florida (US), Pet Releaf (US), and Wet Noses (US).
Posted by at No comments:
Labels:

Ulnar Nerve Treatment Market: 2020 Global Analysis By Opportunities, Size, Share, Growth Factors, Competitive Landscape

Ulnar Nerve Treatment Market Overview
Market Research Future (MRFR) has announced a new release on the global ulnar nerve treatment market. The report examines the ulnar nerve treatment market from the perspective of its leading drivers and restraints, leading geographical segments, and leading players operating in the market. The historical growth patterns of the global ulnar nerve treatment market are assessed in the report to provide a solid platform for reliable predictions about the market’s growth trajectory in the forecast period from 2016 to 2022. The global ulnar nerve treatment market is expected to exhibit a solid CAGR over the forecast period due to the growing prevalence of ulnar nerve damage and the increasing sophistication in its treatment methods.

The ulnar nerve is a nerve running from the shoulder to the little finger. It innervates the little finger and ring finger. It doesn’t have any protective covering in the form of bone or muscles, making it more likely to suffer some form of damage than other nerves. Any direct injury to the nerve can cause significant ulnar nerve damage. Prolonged pressure or repeated motions involving the nerve can also cause ulnar nerve injuries. Diabetes can also cause ulnar nerve damage; patients with diabetes often exhibit ulnar neuropathy at the elbow, more specifically the retrocondylar groove. A fracture to the elbow can also cause ulnar neuropathy, as the nerve passes through the elbow without any protection.

Ulnar nerve damage manifests in the form of pain or loss of sensation in the hand, especially in the area around the ring finger. Weakness and tingling sensations can also be felt in the palm area near the ring finger, leading to a lack of coordination. Ulnar nerve treatment is carried out with the help of painkilling drugs, nerve repair drugs, as well as physical support to help the nerve heal. On rare occasions, ulnar nerve damage may also get better on its own without any external influence.

Ulnar Nerve Treatment Market Segmentation:
The global ulnar never treatment market is segmented by type of treatment, end user, and region.
By treatment type, the global ulnar nerve treatment market is segmented into OTC pain relievers, nerve spasm drugs, physical therapy, and surgery. Of these, nerve spasm drugs are likely to be the dominant contributor to the global ulnar nerve treatment market due to their direct effect on the ulnar nerve and high efficacy.

By end use, the ulnar nerve treatment market is segmented into hospitals and clinics, research centers, and laboratories.

Ulnar Nerve Treatment Market Regional Analysis:
Regionally, the global ulnar nerve treatment market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

North America is likely to remain the leading regional segment of the global ulnar nerve treatment market over the forecast period due to the growing prevalence of ulnar nerve problems and the easy availability of nerve spasm drugs. The advanced healthcare sector in North America is likely to be a major factor in the region retaining the top position in the ulnar nerve treatment market in the coming years. Europe is likely to hold on to second position in the global ulnar nerve treatment market in the coming years due to the steady progress of the healthcare sector in the region.

Asia Pacific is likely to exhibit the fastest growth in the global ulnar nerve treatment market due to the growing healthcare sector and increasing awareness about various conditions. The increasing government efforts to advance the healthcare sector are likely to be the major driver for the ulnar nerve treatment market in Asia Pacific, as a number of governments have taken considerable steps to bring about an improvement in their healthcare sector in recent years.


Ulnar Nerve Treatment Market Competitive Analysis:
Leading players in the global ulnar nerve treatment market include Pfizer Inc., Alkem Labs, Apotex Inc., Mylan NV, Aurobindo Pharma, Amneal Pharmaceuticals LLC, and Teva Pharmaceutical Industries Ltd.
Posted by at No comments:
Labels:

Mental Health Software and Devices Market 2020 Global Trends, Share, Industry Size, Growth, Opportunities And Industry Forecast To 2023

Mental health has come into focus due to changing lifestyles of patients and unhealthy work hours. Mental health software and devices utilizes the power of information technology to keep a check on mental or behavioral disorders. The global mental health software and devices market report by Market Research Future (MRFR) focuses on various issues plaguing the market as well as efforts by manufacturers.

Mental Health Software and Devices Market Outlook
Global mental health software and devices market size can expand from 2017 to 2023 (forecast period) due to the rapid adoption of software by mental health professionals. Change in health practices due to availability of patient records and mental health history can lead to effective management of patients. Collection and analysis of information, elimination of errors, rise in patient income levels, and demand for effective solutions for management of mental health are other drivers of the market.

Development of wearables, changing attitudes of patients and doctors towards information technology, and pressure on hospitals to reduce operational costs can drive the global mental health software and devices market. Real-time monitoring of patient health and provision of advice and medicines via telemedicine can bode well for the market growth in the coming years.

Paucity of skilled personnel, limited insurance coverage costs, and concerns over digital information are challenges faced by the market.

Mental Health Software and Devices Market Segmentation Analysis
the global mental health software and devices market is segmented on the basis of solution, deployment, end users and regions.

By component, the market has been segmented by software and devices. The software has been sub-segmented into web based and standalone software.

By functionality, the market has been segmented by clinical, administrative, financial and others. The clinical segment has been categorized into tele-health, electronic health records (EHRs), E-prescribing, clinical decision support, health management, and others. The administrative has been sub segmented into information management, scheduling, workforce management, and others.

The financial has been sub segmented into accounting, revenue cycle management, business intelligence, and others.

By end user, the market has been segmented by providers, payers, and patients.

Mental Health Software and Devices Market Regional Analysis
Region-wise, the global market comprises North America, Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.

North America accounted for the largest market led by the U.S. due to focus on mental health by governments. According to the American Psychological Association in 2019, the number of young U.S. citizens with an increase of mental health disorders has risen due to shift in mood disorders. Other drivers include rapid adoption of technology and development of healthcare infrastructure by governments.

Europe is the second largest region of the market driven by large number of burnout cases and mental health issues of employees. Governments in the region have developed a common platform for collection of mental health issues and records of patients for implementation of good policies as well as welfare schemes. On the other hand, the APAC region is expected to exhibit the fastest growth rate during the forecast period due to being driven by economies of China, India, and Japan. International brands in the region are giving mental health insurance for preventing burnouts and reducing stress in the workplace.


Mental Health Software and Devices Market Competition Outlook
Prominent mental health software vendors and device manufacturers profiled in the report include Athena Health, Mindlinc, Mentegram, WRS Health, Kareo, Nextgen Healthcare, ICANotes, Core Solutions, InSync Healthcare Solutions, Compulink, Allscripts, Nuesoft Technologies, NextStep Solutions, Valant, Credible Behavioral Health, Welligent, Raintree Systems, Netsmart, Meditab Software, Orion Health, The Echo Group, Sigmund Software, IBM, TheraNest, Advanced Data Systems, AdvancedMD, Qualifacts, McKesson Corporation, iSalus Healthcare, and Cerner Corporation.

Mental Health Software and Devices Industry News
Mental health software providers are currently rolling out a suite of products to lower the stress on non-core functions allowing physicians to focus on patients. Governments are launching websites dedicated to mental health for making it convenient for patients to reach out to doctors in cases of extreme stress.
Posted by at No comments:
Labels:

Chronic Granulomatous Disease Market Overview, Key Players Analysis And Emerging Opportunities

Chronic Granulomatous Disease Market Overview
Market Research Future (MRFR) in its latest report, discusses the growth opportunities of the global chronic granulomatous disease market. It states that the global chronic granulomatous disease market is expected to garner a substantial CAGR over the forecast period of 2018-2023.

Chronic granulomatous disease is a disorder that results in the malfunctioning of the immune system. This leads to immunodeficiency that makes the sufferer prone to different diseases.

The surging patient pool afflicted with chronic diseases and the increase in number of geriatric people are predominant drivers of the global chronic granulomatous disease market. The changing lifestyle and shift in food habits are expected to bolster the market growth. Technical advancements backing medical developments and the existence of influential key players in the market are also likely to provide a fillip to the market growth over the review period.

However, the high treatment cost and lack of awareness about the disease can interfere the global chronic granulomatous disease market growth.

Chronic Granulomatous Disease Market Segmental Overview
The segmental study of the chronic granulomatous disease market helps identify several growth opportunities of the market and prepare strategies that aid in the market proliferation. The chronic granulomatous disease market has been segmented into diagnosis, type, end user, and treatment.

Based on the type, the chronic granulomatous disease market has been segmented into autosomal recessive chronic granulomatous disease and X-linked chronic granulomatous disease.

Based on the diagnosis, the chronic granulomatous disease market has been segmented into genetic testing, neutrophil function tests, prenatal testing, and others.

Based on treatment, the chronic granulomatous disease market has been segmented into stem cell transplantation, infection management, interferon-gamma, and others. The infection management segment has been further classified into itraconazole, trimethoprim, sulfamethoxazole, and others.

Based on the end-use, the chronic granulomatous disease market has been segmented into clinical laboratories, hospitals, and others.

Chronic Granulomatous Disease Market Regional Insights
The demographic progress of the chronic granulomatous disease market can be comprehended from the regional insights of the market. Based on the region, the chronic granulomatous disease market study has been performed across North America, South America, Asia Pacific, Europe, and the Middle East Asia and Africa.

MRFR predicts that the North American chronic granulomatous disease market is expected to be at the forefront during the assessment period. A report published by OMICS International states that about 1 in 200,000 people in the United States.  The firm medical infrastructure, the surge in the prevalence of rare diseases, and an increase in the occurrence of chronic granulomatous disease (CGD) are the factors likely to bolster the regional market.

The high investment in the research and developmental activities concerning chronic granulomatous disease and the surge in prevalence of rare diseases in Europe, are factors that are expected to contribute to the propulsion of the regional market growth in the near future.

The chronic granulomatous disease market in the Asia Pacific is expected to grow at a rapid pace over the forecast period. The presence of emerging economies like China and India, the surge in occurrence of rare diseases and the subsequent growth in the awareness level regarding rare diseases and their management are factors that are identified to augment the regional market growth.

Owing to the unsubstantial medical base and socio-economic backwardness in the Middle East Asia and Africa the chronic granulomatous disease market in the region is expected to experience a stagnancy in its growth. However, the government taking initiatives to improve the healthcare status of the region can boost the market growth. 


Chronic Granulomatous Disease Market Key Players
Horizon Pharma Plc., GlaxoSmithKline Plc, Eli Lilly and Company, Osiris Therapeutics, Inc, JCR, Janssen Pharmaceuticals, Merck KGaA, Pharmaceuticals Co., Ltd., Pfizer, Inc., InterMune, Inc.,  Novartis AG, Lonza Group, and Maxcyte Inc.
Posted by at No comments:
Labels:

Appendiceal Cancer Treatment Market Overview, Key Players Analysis, Emerging Opportunities, Comprehensive Research Study, Competitive Landscape

Appendiceal Cancer Treatment Market Overview
The new report from Market Research Future (MRFR) presents a detailed analysis of the global appendiceal cancer treatment market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global appendiceal cancer treatment market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. 

Various components of the global appendiceal cancer treatment market are also studied in the report and projections are made for the growth trajectory of each distinct component. The various segments and sub-segments within the global appendiceal cancer treatment market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global appendiceal cancer treatment market and provides a detailed look at the various competitive strategies employed by players in the global appendiceal cancer treatment market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.

The increasing awareness about the severity of appendiceal cancer and the growing demand for targeted therapies are likely to be key drivers for the global appendiceal cancer treatment market over the forecast period. While appendiceal cancer is not one of the most common types of cancer, it is still rising in prevalence and is becoming an increasing threat. This has mobilized the healthcare sector to find targeted solutions for appendiceal cancer treatment that can take care of appendiceal cancer comprehensively. This is likely to remain a key driver for the appendiceal cancer treatment market over the forecast period.

Appendiceal Cancer Treatment Market Competitive Analysis:
Leading players in the global appendiceal cancer treatment market include Merck, Amgen Inc., Bayer AG, Sanofi, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, AstraZeneca, General Electric Company, Novartis AG, Becton Dickinson and Company, F. Hoffman-La Roche Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer Inc., and AbbVie Inc.

In January 2018, GE Healthcare announced a long-term partnership with Roche Diagnostics to codevelop and market digital clinical decision support solutions. The primary target of these decision support systems is likely to be cancer diagnosis and improving individualized treatment options for cancer patients.

Appendiceal Cancer Treatment Market Segmentation:
The global appendiceal cancer treatment market is segmented on the basis of type, treatment, end use, and region.
By type, the global appendiceal cancer treatment market is segmented into neuroendocrine tumors and carcinomas. The carcinomas segment is further subsegmented into mucinous adenocarcinoma, goblet cell carcinoids, intestinal-type adenocarcinoma, signet-ring cell adenocarcinoma, and paraganglioma.

By treatment, the global appendiceal cancer treatment market is segmented into surgery, chemotherapy, and radiation therapy. The surgery segment is further subsegmented into appendectomy, hemicolectomy, and cytoreduction. The chemotherapy segment is further subsegmented into hyperthermic intraperitoneal chemotherapy and systemic chemotherapy. The hyperthermic intraperitoneal chemotherapy segment is likely to hold the largest share in the global appendiceal cancer treatment market, as it is highly effective specifically against appendiceal cancer. Systemic chemotherapy is expected to exhibit the highest CAGR over the forecast period, on the other hand.
By end use, the global appendiceal cancer treatment market is segmented into hospitals and clinics, cancer research institutes, and others.


Appendiceal Cancer Treatment Market Regional Analysis:
The Americas is expected to dominate the global appendiceal cancer treatment market due to the favourable reimbursement scenario in the region as well as the growing government support for the same. The increasing support from the government for discovering cures to rare cancers in the U.S. is likely to remain a major driver for the appendiceal cancer treatment market in North America over the forecast period. Europe is likely to hold the second largest share in the global appendiceal cancer treatment market, followed by Asia Pacific, which is expected to exhibit the highest CAGR over the forecast period. The Middle East and Africa is the smallest regional market for appendiceal cancer treatment.
Posted by at No comments:
Labels:

Organic and Natural Tampons Market Trends, Global Analysis With Focus On Opportunities, Sales Revenue, Comprehensive Plans, Growth Potential & Forecast 2023

Organic and Natural Tampons Market Overview
The global organic and natural tampons market is expected to exhibit a strong 8.67% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The Organic and Natural Tampons Market was valued at USD 590.6 million in 2017.

The organic and natural tampons market is mainly driven by the growing awareness about the harmful effect of plastic pollution on the planet, as manufacturers of tampons and other personal hygiene products are increasingly focusing on delivering environmentally viable products that can be used en masse with no damage to the environment. The increasing awareness among consumers about the ecological viability of organic and natural tampons is likely to be a major driver for the global organic and natural tampons market over the forecast period.

The growing population of working women in developed as well as developing countries is also likely to be a major driver for the global organic and natural tampons market over the forecast period. Working women tend to have a higher awareness about the benefits of various tampon products and also tend to be more ecologically conscious, leading to a growing demand from the organic and natural tampons market. The rising prevalence of urinary tract infections among women is also likely to drive the demand for tampon products that don’t contain potentially harmful chemicals, leading to a growing demand from the organic and natural tampons market over the forecast period.

Organic and Natural Tampons Market Competitive Analysis:
Leading players in the global organic and natural tampons market include NutraMarks, TOM Organic, Maxim Hygiene, The Honest Company, Seventh Generation, BON, ALYK, Bodywise, and Procter & Gamble.

In May 2019, Tampax and Always, the feminine hygiene product brands of Procter & Gamble, introduced their first line of organic tampons, branded Pure. The products are made from organic cotton and are free from chemical dyes, chlorine bleach, or artificial fragrances. The two companies also announced that Pure brand organic tampons will incorporate a social welfare scheme, i.e. for every specially marked Pure brand tampon sold, the company will donate one tampon to girls in impoverished communities.

Organic and Natural Tampons Market Segmentation:
The global organic and natural tampons market is segmented on the basis of type, size, odor type, and region.
Based on type, the global organic and natural tampons market is segmented into cardboard applicator, plastic applicator, digital tampon, and others.

Based on size, the organic and natural tampons market is segmented into junior tampons, regular tampons, super tampons, and super-plus tampons. The regular tampons segment accounted for the largest share in the global organic and natural tampons market in 2017 and is likely to hold on to a dominant share over the forecast period.
Based on odor type, the organic and natural tampons market is segmented into fragrance-based and non-fragrance-based. The non-fragrance-based segment is expected to account for the largest share in the market over the forecast period.

Organic and Natural Tampons Market Regional Analysis:
North America dominates the global organic and natural tampons market, followed by Europe. The organic and natural tampons market in both these regions has been driven by the high awareness about feminine hygiene products, the increasing awareness about the environmental footprint of these products, and the growing population of working women. Companies in these two regions are likely to focus on environmental viability as a key USP over the forecast period, as environmental consciousness has steadily grown in these regions and is likely to dominate policy decisions in various sectors over the forecast period.


On the other hand, the organic and natural tampons market has experienced slow growth in developing regions such as Latin America, the Middle East, Africa, and Asia Pacific. The lack of awareness about feminine hygiene products in these regions has been detrimental to the organic and natural tampons market in these regions, as even regular tampons are not used widely. The low disposable income of women in these regions has also contributed to the lack of growth prospects for the global organic and natural tampons market. However, the growing population of working women in Asia Pacific and the increasing awareness about feminine hygiene products in developing countries such as India, China, and South Korea could emerge as significant drivers for the organic and natural tampons market in Asia Pacific over the forecast period.
Posted by at No comments:
Labels:

Pharmacy Repackaging Systems Market Size, Industry Trends, Revenue, Growth Drivers, In-Depth Analysis, Specifications And Forecast 2023

Pharmacy Repackaging Systems Market – Overview
The requirement to ensure considerable reductions in cost and errors is improving the market growth of pharmacy repackaging systems. Reports that review the healthcare industry has been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities. The Pharmacy Repackaging Systems Market is estimated to gain a CAGR of 7 % roughly in the course of the forecast period.

The need to move the pharmaceutical dose from the initial container received from the manufacturer into another container, which is typically tinier in size is the primary factor motivating the market. The development in drug inventory management is encouraging the pharmacy repackaging systems market favorably. Moreover, the availability of automated systems in developed economies is poised to inspire the pharmacy repackaging systems market in the forecast period.

Pharmacy Repackaging Systems Market Segmental Analysis
The segmentation-based study of the pharmacy repackaging systems market is conducted on the basis of dosage type, product type, and end user. Based on the type of product, the market for pharmacy repackaging systems is segmented into liquid medication packaging systems, solid medication packaging systems, bottle filling/ pill counting automation systems, and others. On the basis of dosage type, the pharmacy repackaging systems market is segmented into multiple unit packaging and unit dose packaging. Based on the end user, the pharmacy repackaging systems market is segmented into hospital pharmacy, retail/community pharmacy, long-term care (LTC) pharmacies, and others. Based on the region, the pharmacy repackaging systems market is segmented into Europe, Asia Pacific, the Middle East, the Americas, and Africa.

Pharmacy Repackaging Systems Market Detailed Regional Analysis    
As per the regional study of the pharmacy repackaging systems market, the Americas dominated the market due to the evolution of the market in the North American region. This is principally attributed to factors such as the increasing number of outpatient visits that have boosted the demand from pharmacists and hospitals to include automated systems in order to advance their prescription-handling capability. The European region is anticipated to hold the next largest share in the pharmacy repackaging systems market due to increasing healthcare infrastructure.

Furthermore, numerous initiatives by public and private organizations are estimated to lift the progress of the pharmacy repackaging systems market. The Asia Pacific region is projected to be the fastest increasing region for the pharmacy repackaging systems market. This is due to the technological progress resulting in the expansion of economic pharmacy repackaging systems leading to elevated acceptance rate for the devices in the Asia Pacific region. The Middle East and Africa holds the smallest share in the pharmacy repackaging systems market owing to the incidence of economically varied countries, and fewer initiatives taken by the government.

Pharmacy Repackaging Systems Market Competitive Analysis
In the approaching years, market viability will increasingly improve as modernization, and product advances encourage positive changes. The industry cost make-up is also likely to modify with time. The incidence of popular products and brands is determining the expansion of the market to a significant extent. The strategic success features are also constructively impacting the evolution of the market. The reinforcement of the distribution channels in the market is presumed to augment the saturation of the products. 

The market conditions are extremely dependent on the factors that are influencing the prospects and the challenges that are prevailing in the market. The players in the market are making certain that the product and services being offered in the market are supporting the preferences of their user base favorably. The innovative trends emerging in the market are expected to set the foundation for vigorous development in the forthcoming period. The market size is also anticipated to increase significantly in the approaching years. Also, the development of technology has increased momentum, guiding to improved market growth.


The important contenders in the intraocular lens market are Arxium, Becton Dickinson & Company (Carefusion Corporation), Kirby Lester, Omnicell, Inc, Parata Systems, Pearson Medical Technologies, Medical Packaging Inc, Proficient Rx, Swisslog Holding Ltd, Takazono Corp, Tcgrx and Yuyama Co., Ltd.



Posted by at No comments:
Labels:

Atorvastatin API Market Size, Share, Trends, Top Players, Demands, Overview, Component, Industry Revenue And Forecast

Atorvastatin API Market – Overview
The increasing obesity rates, coupled with an increased incidence of cholesterol problems, is increasing the demand for atorvastatin. Reports that review the healthcare industry have been presented by Market Research Future, which produces reports on industry verticals that appraise the market expansion and prospects. The Atorvastatin API Market is positioned to achieve a CAGR of 3.34% while earning revenues worth USD 4,25,804.16 thousand by 2023.

The need to regulate vital cardiovascular functions is the primary factor fuelling the atorvastatin API market globally. The surging use of atorvastatin to treat cardiovascular diseases is fuelling the development of the market for atorvastatin APIs. The market is expected to be motivated market expansions that are expected to be carried out by industry leaders in the approaching CAGR in the forecast period.

Atorvastatin API Market Segmental Analysis
The segmental study of the atorvastatin API market is carried out on the basis of application and region. The application basis of segmenting the atorvastatin API market is carried out on the basis of hypertriglyceridemia, hypercholesterolemia, dyslipidemia, and others. The hypercholesterolemia segment is anticipated to control the market to touch USD 2,10,753.23 thousand by the end of 2023. The high incidence of hypercholesterolemia is anticipated to initiate positive market growth. Also, the segment is expected to display the uppermost CAGR of 4.09% from 2018 to 2023. The regions counted in the atorvastatin API market are Europe, North America, Asia Pacific, the Middle East, and Africa.

Atorvastatin API Market Detailed Regional Analysis   
The regional review of the atorvastatin API market includes region such as Europe, North America, Asia Pacific, the Middle East, and Africa. The North American region was in charge of the largest market portion of 40.64% in 2017, and the regional market is expected to record a CAGR of 3.10 % through the forecast period. Moreover, the Asia Pacific is projected to utilize the fastest CAGR. The Chinese regional market is projected to display the maximum development rate of 5.86 % during the forecast period from 2018 to 2023. The European regional market is appraised to surpass USD 1,31,094.04 thousand by the year 2023. The high prevalence of mixed dyslipidemia and hypercholesterolemia are impelling the growth of the Atorvastatin API market in the region. France is the key supplier to the development of the regional market, followed by the UK.

Atorvastatin API Market Competitive Analysis
The trade-offs between the resources needed to manage the challenges in the market are being carried out increasingly to improve the market’s scope for development. The need to establish cost-benefit analysis is leading to enhanced product development in the market. The state of the assets is also thoroughly examined to determine whether an investment is required to maintain the marketing system in its existing, unimproved state. The market competitors are also carefully scrutinizing whether intervention is required to ensure efficient use of society’s resources. The development of the alternative courses of action in terms of both their expenses and consequences are steering the growth of the market. The market players are concentrating on strategies that lead to the highest degree of development in the market. They are also making the most effective use of resources which is dependent on an effective appraisal and planning process.

The outstanding leaders in the Atorvastatin API Market globally are Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Morepen Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Anuh Pharma Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Centrient Pharmaceuticals (The Netherlands) and Cadila Pharmaceuticals (India).


Atorvastatin API Industry Updates:
Nov 2018 Zydus Cadila, a well-known Drug maker, has announced that it has received approval from the US health regulator to promote Atorvastatin Calcium tablets, a cholesterol-lowering drug. The group based out of Ahmedabad has obtained final endorsement from the US Food and Drug Administration (USFDA) to sell the drug in the concentrations of 10 mg, 20 mg, 40 mg, and 80 mg respectively.


NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)